Landscapes / Companies
O&D BioTech Group CO., Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
Chimeric antigen receptor T cell O&D-001 targeting BCMA and GPRC5D, Phase 1 trial completes
Drugs
1
in active trials
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | 28 Mar 2028Phase 1 trial completes | |||
| Next date | 28 Mar 2028 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021